Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers

Cited 17 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorS Singh-
dc.contributor.authorV Gajulapati-
dc.contributor.authorK Gajulapati-
dc.contributor.authorJ I Goo-
dc.contributor.authorY H Park-
dc.contributor.authorH Y Jung-
dc.contributor.authorS Y Lee-
dc.contributor.authorJeong Ho Choi-
dc.contributor.authorYoung-Kook Kim-
dc.contributor.authorK Lee-
dc.contributor.authorT H Heo-
dc.contributor.authorY Choi-
dc.date.accessioned2017-04-19T10:18:17Z-
dc.date.available2017-04-19T10:18:17Z-
dc.date.issued2016-
dc.identifier.issn0960-894X-
dc.identifier.uri10.1016/j.bmcl.2016.01.016ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/13157-
dc.description.abstractA series of oxazolidinone and indole derivatives were synthesized and evaluated as IL-6 signaling blockers by measuring the effects of these compounds on IL-6-induced luciferase expression in human hepatocarcinoma HepG2 cells transfected with p-STAT3-Luc. Among different compounds screened, compound 4d was emerged as the most potent IL-6 signaling blockers with IC50 value of 5.9 μM which was much better than (+)-Madindoline A (IC50 = 21 μM), a known inhibitor of IL-6.-
dc.publisherElsevier-
dc.titleStructure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers-
dc.title.alternativeStructure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry Letters-
dc.citation.number4-
dc.citation.endPage1286-
dc.citation.startPage1282-
dc.citation.volume26-
dc.contributor.affiliatedAuthorJeong Ho Choi-
dc.contributor.affiliatedAuthorYoung-Kook Kim-
dc.contributor.alternativeNameSingh-
dc.contributor.alternativeNameGajulapati-
dc.contributor.alternativeNameGajulapati-
dc.contributor.alternativeName구자일-
dc.contributor.alternativeName박연화-
dc.contributor.alternativeName정화영-
dc.contributor.alternativeName이성윤-
dc.contributor.alternativeName최정호-
dc.contributor.alternativeName김영국-
dc.contributor.alternativeName이경-
dc.contributor.alternativeName허태해-
dc.contributor.alternativeName최용석-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry Letters, vol. 26, no. 4, pp. 1282-1286-
dc.identifier.doi10.1016/j.bmcl.2016.01.016-
dc.subject.keywordgp130-
dc.subject.keywordIL-6 antagonists-
dc.subject.keywordIL-6 signaling inhibitor-
dc.subject.keywordOxazolidinone-
dc.subject.keywordRheumatoid arthritis-
dc.subject.keywordSTAT3-
dc.subject.localgp130-
dc.subject.localIL-6 antagonists-
dc.subject.localIL-6 signaling inhibitor-
dc.subject.localOxazolidinone-
dc.subject.localRheumatoid Arthritis-
dc.subject.localRheumatoid arthritis-
dc.subject.localrheumatoid arthritis (RA)-
dc.subject.localrheumatoid arthritis-
dc.subject.localSignal transducer and activator of transcription 3 (STAT3)-
dc.subject.localSignal transducer and activator of transcription-
dc.subject.localSignal transducer and activator of transcription 3 (Stat3)-
dc.subject.localSTAT 3-
dc.subject.localSTAT3-
dc.subject.localSignal transducer and activator of transcription 3-
dc.subject.localStat3-
dc.subject.localSignal transducer and activator of transcription factor 3 (STAT3)-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.